📰 Development Expense News
Page 16 - Development Expense News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Expense. Real-time updates on events, politics, business and more.
September 26, 2022
/PRNewswire/ -- The "Global IoT based Asset Tracking and Monitoring Market Size, Share & Industry Trends Analysis Report By Connectivity Type (Cellular,...
September 6, 2022
/PRNewswire/ -- The "Global Cybersecurity Insurance Market Size, Share & Industry Trends Analysis Report By Component, By Insurance Coverage, By Insurance...
September 6, 2022
/PRNewswire/ -- The "Global Cybersecurity Insurance Market Size, Share & Industry Trends Analysis Report By Component, By Insurance Coverage, By Insurance...
August 9, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the second quarter ended June 30,...
August 9, 2022
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced financial and operating results for the second quarter ended June 30,...
August 8, 2022
Investegate announcements from Nyxoah, Nyxoah Reports Second Quarter and First Half 2022 Financial and Operating Results
August 5, 2022
Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations. The following discussion and analysis provides information that our management believes is relevant to... | August 5, 2022
August 5, 2022
05.08.2022 - FLORHAM PARK, N.J., Aug. 05, 2022 (GLOBE NEWSWIRE) - Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted treatments for cancer, today announced ...
August 4, 2022
The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our unaudited Condensed Consolidated Financial Statements and the... | August 4, 2022
August 3, 2022
VOXZOGO™ $34 Million Contribution Drives Total Revenues of $534 Million in the Quarter; Total Revenues Grew 13% Year-Over-Year, Excluding Kuvan BioMarin...